Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Il-Kang Na, MD, Philipp le Coutre, MD, Christian F. Jehn, MD, Lam G. Vuong, PhD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2014) 124 (21): 2569.

https://doi.org/10.1182/blood.V124.21.2569.2569

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation In Adults With High Risk Acute Lymphoblastic Leukemia (ALL) In 1. Remission (CR1): Promising, But Strongly Influenced By ALL Subtypes

Renate Arnold, MD, Theis H. Terwey, MD, Giang Lam Vuong, MD, Benjamin Ostendorf, MD, Olaf Penack, MD, Gero Massenkeil, MD, Nicola Gökbuget, MD, Philipp Hemmati, MD

Blood (2013) 122 (21): 3409.

https://doi.org/10.1182/blood.V122.21.3409.3409

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status

Philipp Hemmati, MD, Theis H. Terwey, MD, Lam G. Vuong, PhD, Philipp D le Coutre, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2013) 122 (21): 2104.

https://doi.org/10.1182/blood.V122.21.2104.2104

Published: 2013

Journal Articles

Impact of Early Blast Clearance Following Induction Chemotherapy On the Outcome of Patients with Acute Myelod Leukemia Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2012) 120 (21): 1998.

https://doi.org/10.1182/blood.V120.21.1998.1998

Published: 2012

Journal Articles

Prognostic Impact of a Monosomal Karyotype on the Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Philipp G. Hemmati, Theis H. Terwey, Philipp D. le Coutre, MD, Christian Ziegler, Grzegorz Kofla, Gero Massenkeil, MD, Bernd Dörken, Renate Arnold

Blood (2011) 118 (21): 2028.

https://doi.org/10.1182/blood.V118.21.2028.2028

Published: 2011

Journal Articles

NIH-Defined Graft-Versus-Host Disease in Patients with Acute Lymphoblastic Leukemia: Natural History, Prognostic Impact and Effect of Donor Lymphocyte Infusions

Theis H. Terwey, Tanja M. Le Duc, Philipp G. Hemmati, Lam G. Vuong, Peter Martus, Philipp D. le Coutre, MD, Bernd Dörken, Renate Arnold

Blood (2011) 118 (21): 4547.

https://doi.org/10.1182/blood.V118.21.4547.4547

Published: 2011

Journal Articles

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Theis H Terwey, Arturo Vega-Ruiz, Philipp G. Hemmati, Peter Martus, Ekkehart Dietz, Lam G Vuong, Philipp D le Coutre, Bernd Dörken, Renate Arnold

Blood (2010) 116 (21): 899.

https://doi.org/10.1182/blood.V116.21.899.899

Published: 2010

Journal Articles

Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2010) 116 (21): 173.

https://doi.org/10.1182/blood.V116.21.173.173

Published: 2010

Journal Articles

PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003

Nicola Goekbuget, MD, Anja Baumann, MD, Joachim Beck, MD, Monika Brueggemann, MD, Helmut Diedrich, MD, Andreas Huettmann, MD, Lothar Leimer, MD, Stefan Zewen, MD, Martin Mohren, MD, Albrecht Reichle, MD, Markus Schaich, MD, Kerstin Schaefer-Eckart, MD, Marc Schmalzing, MD, Mathias Schmid, MD, Hubert Serve, MD, Reingard Stuhlmann, MD, Theis H Terwey, MD, Dieter Hoelzer, MD

Blood (2010) 116 (21): 494.

https://doi.org/10.1182/blood.V116.21.494.494

Published: 2010

Journal Articles

Pre-Transplant Risk-Assessment for Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplants.

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Lam G Vuong, PhD, Christian Jakob, MD, Arturo Vega, MD, Bernd Dörken, MD, Renate Arnold, MD

Blood (2009) 114 (22): 2302.

https://doi.org/10.1182/blood.V114.22.2302.2302

Published: 2009

Journal Articles

Organ-derived dendritic cells have differential effects on alloreactive T cells

Theo D. Kim, Theis H. Terwey, Johannes L. Zakrzewski, David Suh, Adam A. Kochman, Megan E. Chen, Chris G. King, Chiara Borsotti, Jeremy Grubin, Odette M. Smith, Glenn Heller, Chen Liu, George F. Murphy, Onder Alpdogan, Marcel R. M. van den Brink

Blood (2008) 111 (5): 2929–2940.

https://doi.org/10.1182/blood-2007-06-096602

Published: 2008

Includes: Supplemental data

Journal Articles

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

Philipp G. Hemmati, MD, Gero Massenkeil, MD, Theis H. Terwey, MD, Stefan Neuburger, MD, Philipp le Coutre, MD, Lam Vuong, MD, Bernd Dorken, MD, Renate Arnold, MD

Blood (2007) 110 (11): 3020.

https://doi.org/10.1182/blood.V110.11.3020.3020

Published: 2007

Journal Articles

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Theis H. Terwey, MD, Gero Massenkeil, MD, Ingo Tamm, MD, Christoph Lutz, MD, Philipp Hemmati, MD, Stefan Neuburger, MD, Bernd Dorken, MD, Renate Arnold, MD

Blood (2006) 108 (11): 3004.

https://doi.org/10.1182/blood.V108.11.3004.3004

Published: 2006

Journal Articles

Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine

Elisha Waldman, Sydney X. Lu, Vanessa M. Hubbard, Adam A. Kochman, Jeffrey M. Eng, Theis H. Terwey, Stephanie J. Muriglan, Theo D. Kim, Glenn Heller, George F. Murphy, Chen Liu, Onder Alpdogan, Marcel R. M. van den Brink

Blood (2006) 107 (4): 1703–1711.

https://doi.org/10.1182/blood-2005-08-3445

Published: 2006

Journal Articles

Adoptive Transfer of In Vitro Generated T Cell Precursors Enhances Donor T Cell Reconstitution and Graft-Versus-Tumor Activity in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Johannes L. Zakrzewski, MD, Adam A. Kochman, Sidney X. Lu, Theis H. Terwey, MD, Theo D. Kim, MD, Vanessa M. Hubbard, Stephanie J. Muriglan, David Suh, Javier Cabrera-Perez, Radhika Radhakrishnan, Glenn Heller, PhD, Juan Carlos Zuniga-Pflucker, PhD, Onder Alpdogan, MD, Marcel R.M. van den Brink, MD, PhD

Blood (2005) 106 (11): 63.

https://doi.org/10.1182/blood.V106.11.63.63

Published: 2005

Journal Articles

Graft-Versus-Tumor Activity Against Renal Cell Carcinoma in a Mouse Model of HSCT.

Teresa Ramirez-Montagut, MD, PhD, Andrew Chow, BA (2006), Adam A. Kochman, BS, Vanessa M. Hubbard, BS, David Suh, BA, Odette M. Smith, BA, Hamad Sindhi, BA (2006), Theis H. Terwey, MD, Theo D. Kim, MD, Elisha Waldman, MD, Onder Alpdogan, MD, Marcel R.M. van den Brink, MD, PhD

Blood (2005) 106 (11): 1317.

https://doi.org/10.1182/blood.V106.11.1317.1317

Published: 2005

Journal Articles

Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation

Vanessa M. Hubbard, Jeffrey M. Eng, Teresa Ramirez-Montagut, Kartono H. Tjoe, Stephanie J. Muriglan, Adam A. Kochman, Theis H. Terwey, Lucy M. Willis, Rafaella Schiro, Glen Heller, George F. Murphy, Chen Liu, Onder Alpdogan, Marcel R. M. van den Brink

Blood (2005) 106 (9): 3285–3292.

https://doi.org/10.1182/blood-2005-01-0410

Published: 2005

Journal Articles

CCR2 is required for CD8-induced graft-versus-host disease

Theis H. Terwey, Theo D. Kim, Adam A. Kochman, Vanessa M. Hubbard, Sydney Lu, Johannes L. Zakrzewski, Teresa Ramirez-Montagut, Jeffrey M. Eng, Stephanie J. Muriglan, Glenn Heller, George F. Murphy, Chen Liu, Tulin Budak-Alpdogan, Onder Alpdogan, Marcel R. M. van den Brink

Blood (2005) 106 (9): 3322–3330.

https://doi.org/10.1182/blood-2005-05-1860

Published: 2005

Journal Articles

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation

Onder Alpdogan, Jeffrey M. Eng, Stephanie J. Muriglan, Lucy M. Willis, Vanessa M. Hubbard, Kartono H. Tjoe, Theis H. Terwey, Adam Kochman, Marcel R. M. van den Brink

Blood (2005) 105 (2): 865–873.

https://doi.org/10.1182/blood-2003-09-3344

Published: 2005

Journal Articles

Absence of Inducible Costimulator (ICOS) on Alloreactive T Cells Reduces Graft-versus-Host-Disease While Leaving Graft-Versus-Tumor Activity Intact.

Vanessa M. Hubbard, BS, Jeffrey M. Eng, BA, Kartono H. Tjoe, BA, Teresa Ramirez-Montagut, MD PhD, Stephanie J. Muriglan, MS, Adam A. Kochman, BS, Theis H. Terwey, MD, Raffaella Schiro, MD, Onder Alpdogan, MD, Marcel R.M. van den Brink, MD PhD.

Blood (2004) 104 (11): 592.

https://doi.org/10.1182/blood.V104.11.592.592

Published: 2004

NARROW

Achieving Early Remission By Induction Therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Allogeneic Stem Cell Transplantation In Adults With High Risk Acute Lymphoblastic Leukemia (ALL) In 1. Remission (CR1): Promising, But Strongly Influenced By ALL Subtypes

Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status

Impact of Early Blast Clearance Following Induction Chemotherapy On the Outcome of Patients with Acute Myelod Leukemia Undergoing Allogeneic Stem Cell Transplantation in First Complete Remission

Prognostic Impact of a Monosomal Karyotype on the Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

NIH-Defined Graft-Versus-Host Disease in Patients with Acute Lymphoblastic Leukemia: Natural History, Prognostic Impact and Effect of Donor Lymphocyte Infusions

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003

Pre-Transplant Risk-Assessment for Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplants.

Organ-derived dendritic cells have differential effects on alloreactive T cells

Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning (RIC) Is Effective for Long-Term Disease Control in High-Risk AML Patients in First Complete Remission.

Treatment Strategies for Patients with Relapsed Acute Lymphoblastic Leukemia: Allogeneic Stem Cell Transplantation Is Effective without Prior Reinduction Chemotherapy.

Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine

Adoptive Transfer of In Vitro Generated T Cell Precursors Enhances Donor T Cell Reconstitution and Graft-Versus-Tumor Activity in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Graft-Versus-Tumor Activity Against Renal Cell Carcinoma in a Mouse Model of HSCT.

Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation

CCR2 is required for CD8-induced graft-versus-host disease

Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation

Absence of Inducible Costimulator (ICOS) on Alloreactive T Cells Reduces Graft-versus-Host-Disease While Leaving Graft-Versus-Tumor Activity Intact.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only